Drugs Side Effects in Pregnant Women Infected with HIV Referred to Imam Khomeini Hospital, Voluntary Counseling and Testing Center Tehran, Iran 2009 – 2013 

Authors

  • Minoo Mohraz Iranian Research Center of HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
  • Parvin Salary
  • Zohreh Rostam Afshar
  • Saeed Bayanolhagh
  • Mahboobeh Hajabdolbaghi
  • Fatemeh Jahanjoo Aminabad
  • Pegah Mirzapour
  • Zahra Bayat Jozani
  • Samaneh Moalemi

DOI:

https://doi.org/10.12970/2309-0529.2018.06.04

Keywords:

HIV, pregnant women, Antiretroviral (ARV), adverse effects.

Abstract

 Objective: To have enough information about the prevalence of the ARV side effects in pregnant women infected with HIV and their infants and also evaluate drug efficacy in decreasing HIV infection in their children.

References


[1] Townsend 2008 Hajiabdolbaghi M, Seyedalinaghi A, Zandiyeh S. Applied guideline of confrontation with HIV/AIDS. AIDS research center, Tehran, Iran 2009.
[2] http://www.who.int/hiv/data/en/
[3] Islamic Republic of Iran AIDS Progress Report. National AIDS Committee secretariat ministry of health and medical education. March 2012.
[4] UNAIDS. Countdown to Zero – Global plan towards the Elimination of New HIV infections among children by 2015 and keeping their mothers Alive. (Accessed August 27, 2012).
[5] John GC, Kreiss J. Mother–to-child transmission of human immunodeficiency virus type 1. Epidemiol Rev 1996; 149. https://doi.org/10.1093/oxfordjournals.epirev.a017922
[6] John GC, Nduati RW, Mbori–Ngacha DA, et al. correlates of mother–to–child human immunodeficiency virus type 1 (HIV1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J infect Dis 2001; 183: 206. https://doi.org/10.1086/317918
[7] Fowler MG, Kourtis AP, Aizirey, et al. Breastfeeding and transmission of HIV-1: epidemiology and global magnitude. Adv Exp Med Biol 2012; 743: 30. https://doi.org/10.1007/978-1-4614-2251-8_1
[8] De Cock KM, Fowler MG, Mercier E, et al. prevention of mother- to- child HIV transmission in resource – poor countries; translating research into policy and practice. JAMA 2000; 283: 1175. https://doi.org/10.1001/jama.283.9.1175
[9] Particia M. flynn, Elarine J Abrans-Prenvention of mother–tochild HIV Transmission in resource–limited settings. Nov 6, 2013.
[10] World Health Organizition. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendation for a public health approach, June 30, 2013.
[11] http://WWW.UNAIDS.ORG/en/media/unaids/contentassets/d ocuments/epidemiology/2013/gr2013/UNAIDS-GlobalReport-2013-en.pdf (Accessed on October 11, 2013).
[12] Cooper ER, charural M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1- infected women and prevention of prinatal HIV-1 transmission. J Acquir Immunl Defic Syndr 2002; 29: 484. https://doi.org/10.1097/00042560-200204150-00009
[13] Townsend CL, Cortina–Borja M, Peckham CS, et al. low rates of mother-to–child Transmission of HIV following effective pregnancy interventions in the united kingdom and Ireland, 2000-2006. AIDS 2008; 22: 973. https://doi.org/10.1097/QAD.0b013e3282f9b67a
[14] Chou R, Cantor AG, Zakher B, Bougatsos C. Screening for HIV in pregnant women; systematic review to update the 2005 U.S. Preventive services task force recommendation. Ann Intem Med 2012; 157: 719. https://doi.org/10.7326/0003-4819-157-10-201211200-00009
[15] Center of disease control and prevention. Anemia During Pregnancy in low- income women United States, 1987. Morb Mortal Wkly Rep 1990; 39: 73-6. [pubmed]
[16] Darin A, Chureekatana B, Benjaluckph, Punnee P, Wirach M. Pregnancy outcomes Among HIV-infected women undergoing antiretroviraltherapy. Open AIDS J 2009; 3: 8-13. https://doi.org/10.2174/1874613600903010008
[17] Hoffmann CJ, Thio CL. Clinical implications of HIV and Hepatitis B co-infection in Asia and Africa. Lancet Infect DIS 2007; 7: 402. https://doi.org/10.1016/S1473-3099(07)70135-4
[18] Idoko J, Meloni S, Muazu M, et al. Impact of Hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin Infect Dis 2009; 49: 1268. https://doi.org/10.1086/605675
[19] Hajiabdolbaghi M, Hantooshzadeh S, Ismaeilpoor N, Malekmohamad Meamar F. Evaluation of Epidemidogic, Demographic, Clinical and laboratory information pregnant HIV infected women referred to counseling center of behavioral disease in 2004-2008. Tehran 2009; 43-4.
[20] Suy A, Martinez E, Coll O, et al. Increased risk of preeclampsia and fetal death in HIV- infected pregnant women receiving highly active antiretroviral therapy. AIDS 2006; 20: 59-66. [Pub Med] https://doi.org/10.1097/01.aids.0000198090.70325.bd
[21] Chmait R, Franklin P, Spector SA, Hull Ab. Protease inhibitors and decreased birth weight in HIV infected pregnant women with impaired glucose tolerance. J Principle 2002; 22(5): 370-373. https://doi.org/10.1038/sj.jp.7210748
[22] Shaffer N, Bulterys M, Simonds RY. Short courses of Zidovudine and perinatal transmission of HIV. N Engl Y Med 1999; 340: 1052-30. [Pub Med]

Downloads

Published

2018-05-18

Issue

Vol. 6 No. 1 (2018)

Section

Articles